Expert Rev. Neurotherapeutics 5(1), 85-94 (2005) Neuropsychologic functioning and structural MRI of the brain in patients with schizophrenia

Expert Review of Neurotherapeutics

Volumn 5, Issue 1, 2005, Pages 85-94

  Premkumar, Preethi ^b   Sharma, Tonmoy ^a  

^a NEUROSCIENCE RESEARCH CENTRE   (United Kingdom)

^b ROYAL COLLEGE OF PSYCHIATRISTS   (United Kingdom)

Author keywords

Brain structure; Duration of untreated psychosis; First episode; Longitudinal; Magnetic resonance imaging; Neuropsychologic function; Schizophrenia

Indexed keywords

HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE;

ANHEDONIA; BASAL GANGLION; BRAIN FUNCTION; COGNITIVE DEFECT; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; INTELLIGENCE QUOTIENT; MEMORY DISORDER; NEUROIMAGING; NEUROPATHOLOGY; NEUROPSYCHOLOGY; PARANOID SCHIZOPHRENIA; PSYCHOLOGIC ASSESSMENT; REVIEW; TEMPORAL LOBE; VARIANCE; VERBAL MEMORY; WISCONSIN CARD SORTING TEST; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; PSYCHOLOGY; SCHIZOPHRENIA;

ANTIPSYCHOTIC AGENTS; HUMANS; MAGNETIC RESONANCE IMAGING; NEUROPSYCHOLOGICAL TESTS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 12344277539     PISSN: 14737175     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737175.5.1.85     Document Type: Review

References (101)

1. Heinrichs RW, Zakzanis KK. Neurocognitive deficits in schizophrenia: a quantitative review of the evidence. Neuropsychology 12, 426-445 (1998).
2. Lawrie SM, Abukmeil SS. Brain abnormality in schizophrenia: a systematic and quantitative review of volumetric magnetic resonance imaging studies. Br. J. Psych. 172, 110-120 (1998).
3. DeLisi LE, Tew W, Xie S et al. A prospective follow-up study of brain morphology and cognition in first-episode schizophrenic patients: preliminary finding. Biol. Psychiatry 38(6), 349-360 (1995).
4. Gur RE, Cowell P, Turetsky BI et al. A follow-up magnetic resonance imaging study of schizophrenia. Relationship of neuroanatomical changes to clinical and neurobehavioral measures. Arch. Gen. Psych. 55, 145-152 (1998).
5. Johannessen JO, McGlashan TH, Larsen TK et al. Early detection strategies for untreated first-episode psychosis. Schizophr. Res. 51(1), 39-46 (2001).
6. Robinson D, Woerner MG, Alvir JM et al. Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Arch. Gen. Psych. 56(3), 241-247 (1999).
7. McGlashan TH, Johannessen JO. Early detection and intervention with schizophrenia: rationale. Schizophr. Bull. 22(2), 201-22 (1996).
8. Sharma T. Structural and functional endophenotypes in schizophrenia. In: Neurobiology and Psychiatry. Volume 3. Kerwin R, Dawbarn D, McCulloch J, Tamminga C (Eds). Cambrige University Press, Cambridge, UK, 25-32 (1995).
9. McGorry PD, Yung AR, Phillips LJ. The 'close-in' or ultra high-risk model: a safe and effective strategy for research and clinical intervention in prepsychotic mental disorder. Schizophr. Bull. 29(4), 771-790 (2003).
10. Karmiloff-Smith A. Beyond Modularity: a Developmental Perspective on Cognitive Science. MIT Press, MA, USA (1992).
11. Fodor JA. The Modularity of Mind: an Essay on Faculty Psychology. MIT Press, MA, USA (1983).
12. Pinel J. Biopsychology. Allyn & Bacon, Canada (1993).
13. Bilder RM, Goldman RS, Robinson D et al. Neuropsychology of first-episode schizophrenia: initial characterisation and clinical correlates. Am. J. Psychiatry 157, 549-559 (2000).
14. Saykin AJ, Derri LS, Gur RE et al. Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia. Arch. Gen. Psych. 41, 124-131 (1994).
15. Saykin AJ, Gur RC, Gur RE et al. Neuropsychological function in schizophrenia. Selective impairment in memory and learning. Arch. Gen. Psych. 48(7), 618-624 (1991).
16. Aleman A, Hijman R, de Haan EHF, Kahn RS. Memory impairment in schizophrenia: a meta-analysis. Am. J. Psych. 156, 1358-1366 (1999).
17. Riley EM, McGovern D, Mockler D et al. Neuropsychological functioning in first-episode psychosis - evidence of specific deficits. Schizophr. Res. 43, 47-55 (2000).
18. Kremen WS, Seidman LJ, Pepple JR, Lyons MJ, Tsuang MT, Faraone SV. Neuropsychological risk indicators for schizophrenia: a review of family studies. Schizophr. Bull. 20(1), 103-119 (1994).
19. Church SM, Cotter D, Bramon E, Murray RM. Does schizophrenia result from developmental or degenerative processes? J. Neural. Trans. 63(Suppl.), 129-147 (2002).
20. Caspi A, Reichenberg A, Weiser M et al. Cognitive performance in schizophrenia patients assessed before and following the first psychotic episode. Schizophr. Res. 65(2-3), 87-94 (2003).
21. Gold S, Arndt S, Nopoulos P, O'Leary D, Andreasen NC. Longitudinal study of cognitive function in first-episode and recent-onset schizophrenia. Am. J. Psych. 156, 1342-1348 (1999).
22. Censits DM, Ragland JD, Gur RC, Gur RE. Neuropsychological evidence supporting a neurodevelopmental model of schizophrenia: a longitudinal study. Schizophr. Res. 24, 289-298 (1997).
23. Hoff AL, Sakuma M, Wieneke MH, Horon R, Kushner M, DeLisi LE. Longitudinal neuropsychological follow-up study of patients with first-episode schizophrenia. Am. J. Psych. 156(9), 1336-1341 (1999).
24. Stirling J, White C, Lewis S et al. Neurocognitive function and outcome in first-episode schizophrenia: a 10-year follow-up of an epidemiological cohort. Schizophr. Res. 65(2-3), 75-86 (2003).
25. Mortimer AM. Cognitive function in schizophrenia - do neuroleptics make a difference? Pharmacol. Biochem. Behav. 56, 789-795 (1996).
26. Cassens G, Inglis AK, Applebaum PS et al. Neuroleptics: effects on neuropsychological function in chronic schizophrenic patients. Schizophr. Bull. 16, 477-499 (1990).
27. Spohn HE, Strauss ME. Relation of neuroleptic and anticholinergic medication to cognitive functions in schizophrenia. J. Ab. Psychol. 98, 367-380 (1989).
28. Stip E, Lussier I, Ngan E, Mendrek A, Liddle P. Discriminant cognitive factors in responder and non-responder patients with schizophrenia. Eur. Psych. J. Assoc. Eur. Psych. 14(8), 442-450 (1999).
29. Sharma T. Cognitive effects of conventional and atypical antipsychotics in schizophrenia. Br. J. Psychiatry 17(Suppl. 38), 44-51 (1999).
30. Keefe RS, Seidman LJ, Christensen BK et al. Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol. Am. J. Psychiatry 161(6), 985-995 (2004).
31. Townsend LA, Malla AK, Norman RMG. Cognitive functioning in stabilized first-episode psychosis patients. Psych. Res. 104(2), 119-131 (2001).
32. Townsend LA, Norman RM, Malla AK, Rychlo AD, Ahmed RR. Changes in cognitive functioning following comprehensive treatment for first episode patients with schizophrenia spectrum disorders. Psych. Res. 113(1-2), 69-81 (2002).
33. Schuepbach D, Keshavan MS, Kmiec JA, Sweeney JA. Negative symptom resolution and improvements in specific cognitive deficits after acute treatment in first-episode schizophrenia. Schizophr. Res. 53(3), 249-261 (2002).
34. Carbone SH, McGorry PD, Curry C, Elkins K. Duration of untreated psychosis and 12-month outcome in first-episode psychosis: the impact of treatment approach. Acta Psychiatrica Scandinavica 100, 96-104 (1999).
35. McGlashan TH. Duration of untreated psychosis in first-episode schizophrenia: marker or determinant of course. Biol. Psych. 46, 899-907 (1999).
36. Wyatt RJ, Heuter I. Rationale for the study of early intervention. Schizophr. Res. 51, 69-76 (2001).
37. Amminger GP, Edwards J, Brewer WJ, Harrigan S, McGorry PD. Duration of untreated psychosis and cognitive deterioration in first-episode schizophrenia. Schizophr. Res. 54(3), 223-230 (2002).
38. Rund BR, Meile I, Friis S et al. Neurocognitive dysfunction in first-episode psychosis: correlates with symptoms, premorbid adjustment, and duration of untreated psychosis. Am. J. Psychiatry 161 (3), 466-472 (2004).
39. Ho BC, Alicata D, Ward J et al. Untreated initial psychosis: relation to cognitive deficits and brain morphology in first-episode schizophrenia. Am. J. Psychiatry 160(1), 142-148 (2003).
40. Heydebrand G, Weiser M, Rabinowitz J, Hoff AL, DeLisi LE, CsernanskyJG. Correlates of cognitive deficits in first episode schizophrenia. Schizophr. Res. 68(1), 1-9 (2004).
41. Crow TJ, MacMillan JF, Johnson AL, Johnstone EC. A randomized controlled trial of prophylactic neuroleptic treatment. Br. J. Psychiatry 148, 120-127 (1986).
42. Hawkins KA, Addington J, Keefe RS et al. Neuropsychological status of subjects at high risk for a first episode of psychosis. Schizophr. Res. 67(2-3), 115-122 (2004).
43. McCarley RW, Wible CG, Frumin M et al. MRI anatomy of schizophrenia. Biol. Psych. 45, 1099-1119 (1999).
44. Wright IC, Rabe-Hesketh S, Woodruff PWR, David AS, Murray RM, Bullmore ET. Meta-analysis of regional brain volumes in schizophrenia. Am. J. Psychiatry 157, 16-25 (2000).
45. Fannon D, Chitnis XVD, Tennakoon L et al. Features of structural brain abnormality detected in first-episode psychosis. Am. J. Psychiatry 157, 1829-1834 (2000).
46. Ettinger U, Chitnis XA, Kumari V et al. Magnetic resonance imaging of the thalamus in first-episode psychosis. Am. J. Psychiatry 158(1), 116-118 (2002).
47. Gur RE, Turetsky BI, Cowell PE et al. Temporolimbic volume reductions in schizophrenia. Arch. Gen. Psych. 57(8), 769-775 (2000).
48. Woodruff PW, Wright IC, Bullmore ET et al. Auditory hallucinations and the temporal cortical response to speech in schizophrenia: a functional magnetic resonance imaging study. Am. J. Psychiatry 154(12), 1676-1682 (1997).
49. Squire LR, Zola SM. Loss of recent memory after bilateral hippocampal lesions. In: Cognitive Neuroscience. Gazzaniga MS (Ed.). Blackwell Publishers Ltd, Oxford, UK (2000).
50. Campeau S, Hayward MD, Hope BT, Rosen JB, Nestler EJ, Davis M. Induction of the c-fos proto-oncogene in rat amygdala during unconditioned and conditioned fear. Brain Res. 565, 349-352 (1991).
51. Pascoe JP, Kapp BS. Electrophysiological characteristics of amygdaloid central nucleus neurons during Pavlovian fear conditioning in the rabbit. Behav. Brain Res. 16, 117-113 (1985).
52. Nelson MD, Saykin AJ, Flashman LA, Riordan HJ. Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging: a metaanalytic study. Arch. Gen. Psych. 55(5), 433-440 (1998).
53. Sumich A, Chitnis XA, Fannon DG et al. Temporal lobe abnormalities in first-episode psychosis. Am. J. Psychiatry 159, 1232-1234 (2002).
54. Joyal CC, Laakso MP, Tiihonen J et al. The amygdala and schizophrenia: a volumetric magnetic resonance imaging study in first-episode, neuroleptic-naive patients. Biol. Psych. 54(11), 1302-1304 (2003).
55. Laakso MP, Tiihonen J, Syvälahti E et al. A morphometric MRI study of the hippocampus in first-episode neuroleptic-naive schizophrenia. Schizophr. Res. 50, 3-7 (2001).
56. Gonzalez Ballaster MA, Zisserman AP, Brady M. Estimation of the partial volume effect in MRI. Medical Image Anal. 6, 389-405 (2002).
57. Ashburner J, Fristen KJ. Voxel-based morphometry - the methods. Neuroimage 11, 805-821 (2000).
58. Narr KL, Thompson PM, Szeszko P et al. Regional specificity of hippocampal volume reductions in first-episode schizophrenia. Neuroimage 21(4), 1563-1575 (2004).
59. Andreasen NC. Image processing for the study of brain structure and function, problems and programs. J. Neuropsych. Clin. Neurosci. 4, 125-133 (1992).
60. Ashburner J. Computer-assisted imaging to assess brain structure in healthy and diseased brains. Lancet Neurology 2, 79-88 (2003).
61. Kadar T, Dachir S, Shukitt-Hale B, Levy B. Sub-regional hippocampal vulnerability in various animal models leading to cognitive dysfunction. J. Neural Trans. 105, 987-1004 (1998).
62. Velakoulis D, Pantelis C, McGorry PD et al. Hippocampal volume in first-episode psychoses and chronic schizophrenia. Arch. Gen. Psych. 56, 133-140 (1999).
63. Ingvar DH, Franzen G. Abnormalities of cerebral blood flow distribution in patients with chronic schizophrenia. Acta Psychiatrica Scandinavica 50, 425-462 (1974).
64. Andreasen NC, O'Leary DS, Flaum M, Watkins GL, Ponto LLB. Hypofrontality in schizophrenia: distributed dysfunctional circuits in neuroleptic-naive patients. Lancet 349, 1730-1734 (1997).
65. Hirayasu Y, Tanaka S, Shenton ME et al. Prefrontal gray matter volume reduction in first episode schizophrenia. Cerebral Cortex 11, 374-381 (2001).
66. Molina V, Sanz J, Sarramea F, Benito C, Palamo T. Lower prefrontal gray matter volume in schizophrenia in chronic but not in first episode schizophrenia patients. Psych. Res. Neuroimag. 131, 45-56 (2004).
67. Szeszko PR, Bilder RM, Lencz T et al. Investigation of frontal lobe subregions in first-episode schizophrenia. Psych. Res. Neuroimag 90, 1-15 (1999).
68. Crespo-Facorro B, Kim JJ, Andreasen NC, O'Leary DS, Magnotta V. Regional frontal abnormalities in schizophrenia: a quantitative gray matter volume and cortical surface size study. Biol. Psych. 48, 110-119 (2000).
69. Chakos MH, Lieberman JA, Alvir J, Bilder R, Ashtari M. Caudate nuclei volumes in schizophrenic patients treated with typical antipsychotics or clozapine. Lancet 345(8947), 456-457 (1995).
70. Graybiel AM, Kimura M. Adaptive neural networks in the basal ganglia. In: Models of Information Processing in the Basal Ganglia. Houk JC, Davis JL, Beiser DG (Eds). MIT Press, MA, USA (1995).
71. Hikosaka O, Rand MK, Miyachi S, Miyashita K. Procedural learning in the monkey. In: Functions of the Cortico-Basal Ganglia Loop. Kimura M, Graybiel AM (Eds). Springer-Verlag, NY, USA, 18-30 (1995).
72. Buchsbaum MS, Shihabuddin L, Brickman AM et al. Caudate and putamen volumes in good and poor outcome patients with schizophrenia. Schizophr. Res. 64, 53-62 (2003).
73. Laakso A, Vilkman H, Alakare B et al. Striatal dopamine transporter binding in neuroleptic-naive patients with schizophrenia studied with positron emission tomography. Am. J. Psychiatry 157(2), 269-271 (2000).
74. Laakso A, Bergman J, Haaparanta M et al. Decreased striatal dopamine transporter binding in vivo in chronic schizophrenia. Schizophr. Res. 52(1-2), 115-120 (2001).
75. Livingston MG. Regional cerebral blood flow in first-episode schizophrenia patients before and after antipsychotic drug treatment. Acta Psychiatrica Scandinavica 97(6), 440-449 (1998).
76. Gunduz H, Wu H, Ashtari M et al. Basal ganglia volumes in first-episode schizophrenia and healthy comparison subjects. Biol. Psych. 51(10), 801-808 (2002).
77. Corson PW, Nopoulos P, Andreasen NC, Heckel D, Arndt S. Caudate size in first-episode neuroleptic-naive schizophrenic patients measured using an artificial neural network. Biol. Psych. 46(5), 712-720 (1999).
78. Gur RE, Maany V, Mozley PD, Swanson C, Bilker W, Gur RC. Subcortical MRI volumes in neuroleptic-naive and treated patients with schizophrenia. Am. J. Psychiatry 155(12), 1711-1717 (1998).
79. Chakos MH, Lieberman JA, Bilder RM et al. Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs. Am. J. Psychiatry 151(10), 1430-1436 (1994).
80. Lang DJ, Kopala LC, Vandorpe RA et al. An MRI study of basal ganglia volumes in first-episode schizophrenia patients treated with risperidone. Am. J. Psychiatry 158(4), 625-631 (2001).
81. DeLisi LE, Sakuma M, Tew W, Kushner M, Hoff AL, Grimson R. Schizophrenia as a chronic active brain process: a study of progressive brain structural change subsequent to the onset of schizophrenia. Psych. Res. Neuroimag. 74(3), 129-140 (1997).
82. Harrison PJ. The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain 122(Pt 4), 593-624 (1999).
83. Stevens JR. Schizophrenia: static or progressive pathophysiology? Schizophr. Res. 5, 184-186 (1991).
84. Woods BT. Is schizophrenia a progressive neurodevelopmental disorder? Am. J. Psych. 155, 1661-1670 (1998).
85. Garver DL, Nair TR, Christensen JD, Holcomb JA, Kingsbury SJ. Brain and ventricle instability during psychotic episodes of the schizophrenias. Schizophr. Res. 44, 11-23 (2000).
86. Weinberger DR, McClure RK. Neurotoxicity, neuroplasticity, and magnetic resonance imaging morphometry: what is happening in the schizophrenic brain? Arch. Gen. Psych. 59, 553-558 (2002).
87. Gharaibeh WS, Rohlf FJ, Slice DE, DeLisi LE. A geometric morphometric assessment of change in midline brain structural shape following a first episode of schizophrenia. Biol. Psych. 48, 398-405 (2000).
88. DeLisi LE, Sakuma M, Ge S, Kushner M. Association of brain structural change with the heterogeneous course of schizophrenia from carry childhood through five years subsequent to a first hospitalisation. Psych. Res. 84, 75-88 (1998).
89. Lieberman JA, Chakos M, Wu H et al. Longitudinal study of brain morphology in first episode schizophrenia. Biol. Psych. 49, 487-499 (2001).
90. Wood SJ, Velakoulis D, Smith DJ et al. A longitudinal study of hippocampal volume in first episode psychosis and chronic schizophrenia. Schizophr. Res. 52, 37-46 (2001).
91. Kasai K, Shenton ME, Salisbury DF et al. Progressive decrease of left superior temporal gyrus gray matter volume in patients with first-episode schizophrenia. Am. J. Psychiatry 160(1), 156-164 (2003).
92. Pakkenberg B. Total nerve cell number in neocrotex in chronic schizophrenics and controls estimated using optical dissectors. Biol. Psych. 34, 768-772 (1993).
93. Selemon LD, Rajkowska G, Goldman-Rakic PS. Elevated neuronal density in prefrontal area 46 in brains from schizophrenic patients: application of a three-dimensional, sterological counting method. J. Comp. Neurol. 392, 402-412 (1998).
94. Akbarian S, Kim JJ, Potkin SG, Herrick WP, Bunney WE Jr, Jones EG. Maldistribution of interstitial neurons in prefrontal white matter of the brains of schizophrenic patients. Arch. Gen. Psych. 53, 425-436 (1996).
95. Benes FM, Sorenson I, Bird ED. Reduced neuronal size in posterior hippocampus of schizophrenic patietns. Schizophr. Bull. 17, 597-608 (1991).
96. Gluck MR, Thomas RG, Davis KL, Haroutunian V. Implications for altered glutamate and GABA metabolism in the dorsolateral prefrontal cortex of aged schizophrenic patients. Am. J. Psychiatry 159(7), 1165-1173 (2002).
97. Deakin JF, Simpson MD. A two-process theory of schizophrenia: evidence from studies in post-mortem brain. J. Psych. Res. 31(2), 277-295 (1997).
98. Deakin JF, Simpson MD. A two-process theory of schizophrenia: evidence from studies in post-mortem brain. J. Psych. Res. 31(2), 277-295 (1997).
99. Bilder R, Bogerts B, Ashtari M et al. Anterior hippocampal volume reductions predict frontal lobe dysfunction in first episode schizophrenia. Schizophr. Res. 17, 47-58 (1995).
100. Szeszko PR, Strous RD, Goldman RS et al. Neuropsychological correlates of hippocampal volumes in patients experiencing a first episode of schizophrenia. Am. J. Psychiatry 159, 217-226 (2002).
101. Antonova E, Sharma T, Morris R, Kumari V. The relationship between brain structure and neurocognition in schizophrenia: a selective review. Schizophr. Res. 70, 117-145 (2004).